# clm_33823C33ED82

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_research_and_development  
value: 224,045,000 United States dollar  
valid_from: 2013-09-30  
valid_to: 2014-03-31  
published: 2013-11-05  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_298FEDBEF107  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly research and development: 224,045,000 United States dollar", as of 2013-09-30 (until 2014-03-31). Claim clm_33823C33ED82, https://asof.is/claim/clm_33823C33ED82, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:ResearchAndDevelopmentExpense in 10-Q Q3 FY2013, filed 2013-11-05  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000153217613000030/0001532176-13-000030-index.htm (primary, SEC EDGAR 10-Q Q3 FY2013, published 2013-11-05)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_research_and_development | 187,463,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_33823C33ED82](/claim/clm_33823C33ED82.md) | [clm_B00FA7DE5A26](/claim/clm_B00FA7DE5A26.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.